Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Type

Guidance programme

Guidance programme

HealthTech approach

HealthTech approach

Advice programme

Area of interest

Showing 1051 to 1075 of 2555

Published guidance, NICE advice and quality standards
TitleReference numberPublishedLast updated
Electrical stimulation to improve muscle strength in chronic respiratory conditions, chronic heart failure and chronic kidney diseaseHTG549
Transcranial magnetic stimulation for obsessive-compulsive disorderHTG548
Treosulfan with fludarabine for malignant disease before allogeneic stem cell transplantTA640
Renal and ureteric stonesQS195
Artificial iris insertion for acquired aniridiaHTG546
Artificial iris insertion for congenital aniridiaHTG547
Remsima (infliximab biosimilar) for subcutaneous injection for managing rheumatoid arthritisES29
Specialist neonatal respiratory care for babies born pretermQS193
CFHealthHub for managing cystic fibrosis during the COVID-19 pandemicMIB219
Atezolizumab with nab-paclitaxel for untreated PD-L1-positive, locally advanced or metastatic, triple-negative breast cancerTA639
Atezolizumab with carboplatin and etoposide for untreated extensive-stage small-cell lung cancerTA638
Daratumumab with lenalidomide and dexamethasone for untreated multiple myeloma (terminated appraisal)TA634
Ramucirumab with erlotinib for untreated EGFR-positive metastatic non-small-cell lung cancer (terminated appraisal)TA635
Eculizumab for treating refractory myasthenia gravis (terminated appraisal)TA636
Ranibizumab for treating diabetic retinopathy (terminated appraisal)TA637
Rezum for treating lower urinary tract symptoms secondary to benign prostatic hyperplasiaHTG545
Avatrombopag for treating thrombocytopenia in people with chronic liver disease needing a planned invasive procedureTA626
MolecuLight i:X for wound imagingMIB212
Actim Pancreatitis for diagnosing acute pancreatitisMIB218
Tests to help assess risk of acute kidney injury for people being considered for critical care admission (ARCHITECT and Alinity i Urine NGAL assays, BioPorto NGAL test and NephroCheck test)HTG544
Ustekinumab for treating moderately to severely active ulcerative colitisTA633
Generalised anxiety disorder and panic disorder in adults: managementCG113
Archimedes for biopsy of suspected lung cancerMIB211
Intravenous fluid therapy in children and young people in hospitalNG29
Trastuzumab emtansine for adjuvant treatment of HER2-positive early breast cancerTA632

Results per page

  1. 10
  2. 25
  3. 50
  4. All